Exit this survey

1. Evaluation and Quiz for Pharmacy Grand Round - June 22, 2017

Thank you for participating in the Pharmacy Grand Round - Review of Cariprazine, Brexpiprazole, and Lurasidone on June 22, 2017

Question Title

* 1. First Name:

Question Title

* 2. Last Name:

Question Title

* 3. Please indicate your health care profession.

Question Title

* 4. What is the name of your organization?

Question Title

* 5. What is the city?

Question Title

* 6. What is the name of the county?

Question Title

* 7. What is zip code?

Question Title

* 8. Phone Number:

Question Title

* 9. Fax Number:

Question Title

* 10. Email Address (required):

This is the quiz portion: (Pharmacists and Pharmacy Techs must complete this portion) You have to pass with a 66% in order to receive a certificate.

Question Title

* 11. A significant drug interaction is likely between erythromycin, a potent CYP3A4 inhibitor, and which of the following?

Question Title

* 12. For which of the following indications (either as monotherapy or as adjunct to traditional agents) are ALL of these drugs FDA approved (lurasidone, brexpiprazole, and cariprazine)?

Question Title

* 13. Which of the following is an advantage of brexpiprazole over cariprazine and lurasidone?

Question Title

* 14. Which of the following is proposed as the pharmacological difference between cariprazine and current second generation antipsychotics that leads to beneficial effects in schizophrenia? Compared to second generation antipsychotics, cariprazine exhibits more:

This begins the evaluation portion.

Question Title

* 15. Please indicate how well this speaker met each of the stated learning objectives:

  Strongly Agree Agree Undecided Disagree Strongly Disagree
• List the FDA approved indications
• Describe their pharmacological mechanisms of action
• Describe the efficacy compared to traditional therapeutic alternatives
• List common and/or dose-dependent side effects reported for each agent
• List anticipated drug interactions based on the known metabolism of each agent

Question Title

* 16. Please evaluate the content.

  Strongly Agree Agree Undecided Disagree Strongly Disagree
a. The content was clearly organized.
b. The content had a good blend of theoretical and practical information.

Question Title

* 17. Please evaluate the presenter: Craig M. Straley, Pharm.D., BCPP, effectiveness:

  Strongly Agree Agree Undecided Disagree Strongly Disagree
a. The presenter was knowledgeable.
b. The presenter was well prepared.
c. The presenter answered questions adequately/clearly.

Question Title

* 18. Please evaluate the instructional strategies.

  Strongly Agree Agree Undecided Disagree Strongly Disagree
a. I will be able to transfer this content to my work environment.
b. The educational activity site/room/time was convenient.

Question Title

* 19. Overall satisfaction

  Strongly Agree Agree Undecided Disagree Strongly Disagree
Overall, I am satisfied with this educational activity.

Question Title

* 20. What educational sessions would you like offered? (This will help us in designing future program offerings.)

Question Title

* 21. Comments

Thank you for participating in the Pharmacy Grand Round program on June 22, 2017 and completing the evaluation for this program. Remember, all pharmacists and pharmacy techs must also complete the quiz in order to receive a certificate. If you have any questions, please contact Victoria Lantzy at (517) 355-8250.

T